New Product Development
[341 Pages Report] Cancer, cardiovascular diseases, and metabolic diseases like diabetes, are the main cause of mortality and disability in present times. Even with the understanding of scientific disease indications, it is crucial to elevate diagnosis and control the symptoms and signs of illness. According to the Future Market Insights’ analysis, the injectable drugs market is set to …
Continue reading “Injectable Drugs Market with revenue expected to reach US$ 840.8 Mn by 2031 | FMI”
Global Insulin Delivery Pens Market: Dynamics Several factors contribute to the growth of the global insulin delivery pens market. One major driver is the move towards value based compensation models for therapies from unit priced payment models that are more commonly used to self-administer treatment for chronic diseases like diabetes. The shift is prominently seen in …
[200 Pages Report] According to Future Market Insights (FMI), the demand for insulin pens is expected to rise considerably in the coming decade, enabling the market to surpass a valuation of US$ 30,407.5 Mn by the end of 2021. Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To …
Continue reading “Insulin Pens Market value is forecast to reach US$ 46,906.4 Mn by 2031 | FMI”
The Insulin Pumps Market revenues were estimated at US$ 5.5 Bn in 2022 and is anticipated to grow at a CAGR of 10.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 14.8 Bn. The demand for tethered pumps is projected to garner an absolute dollar opportunity of …
The Outpatient Clinics Market is anticipated to reach US$ 39.0 billion by the end of 2022 and continue to grow at a CAGR of 4.2% from 2022 to 2032. By the end of 2032, the market is anticipated to have a US$58.9 billion valuation. The market is being led by primary care clinics, which in …
Global Intravenous Iron Drugs Market was valued at US$ 2.6 Bn in 2021 and is expected to reach US$ 6.3 Bn by 2032, finds Fact.MR in a recent market survey. As per the findings of the report, Intravenous Iron Drugs revenue through Ferric Carboxymaltose will garner significant demand in the market as the bulk of revenue will …
Over the forecast period (2022-2032), it is expected that worldwide sales of Over-The-Counter (OTC) Veterinary Drugs Market medications would increase at a CAGR of 8.1% and reach US$ 18.14 Bn by the end of 2032. In 2021, online pharmacies held a market share of more than 38%. According to Future Market Insights, the global over-the-counter (OTC) …
[297 Pages Report] The global IoT in healthcare market is projected to reach US$ 181.4 Billion in 2022, anticipated to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032. The market is slated to document a Y-o-Y growth rate of 20.7% from 2021-2022, increasing from the previously registered value of US$ 150.3 Billion. By …
The global Oligonucleotide API Market is expected to reach US$ 2.46 billion in 2022, with a CAGR of 10.2% through 2030, according to FMI, an ESOMAR-certified market research firm. According to FMI’s analysis, as of now, 100+ oligonucleotide APIs are in the clinical trials’ phase, and regulatory approval is on the cards. Post-approval, the demand …
Continue reading “Oligonucleotide API Market is expected to expand at a CAGR of 10.2% through 2030”
The global keloid treatment market size reached US$ 3.6 Bn in 2021 and is expected to enjoy a valuation of US$ 3.7 Bn by the end of 2022. Furthermore, with rising prevalence of keloid across the world, the overall demand for keloid treatment is set to grow at 3.2% CAGR between 2022 and 2032, totalling a valuation of ~US$ 5.1 Bn by 2032. Global Keloid Treatment Market: …